相关实验视频
Updated: Sep 13, 2025

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation
Published on: January 28, 2021
脂蛋白 (a):药理学研究的新目标和治疗选择
Angela Pirillo1, Alberico L Catapano2
1Center for the Study of Atherosclerosis, E. Bassini Hospital, Cinisello Balsamo, Milan, Italy.
脂蛋白 (Lp) 是心血管疾病的关键遗传风险因素. 新疗法在降低Lp (a) 水平方面表现有希望,可能改善心血管风险评估和治疗.
科学领域:
- 心血管医学 心血管医学
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 脂蛋白 (Lp) 是动脉样硬化心血管疾病 (ASCVD) 和动脉狭窄症 (AVS) 的独立风险因素.
- 血Lp (a) 水平主要由基因决定,在一生中保持稳定,对生活方式变化和标准疗法有抗性.
- 升高的Lp (a) 与ASCVD风险增加有关,特别是在家族性高胆固醇血症或较小的阿波利波蛋白 (a) [阿波利波蛋白 (a) ]异型中.
研究的目的:
- 审查Lp (a) 在心血管疾病中的作用.
- 讨论新的Lp降低疗法及其对临床实践的潜在影响.
- 为了突出Lp的挑战,测量和标准化.
主要方法:
- 对Lp的遗传,流行病学和临床证据的审查.
- 分析新兴的基于RNA的疗法 (抗意义寡核酸,小干扰RNA) 和小分子抑制剂.
- 讨论正在进行的临床试验,评估心血管结果.
主要成果:
- 像佩拉卡森 (pelacarsen),奥尔帕西兰 (olpasiran),勒波迪西兰 (lepodisiran),泽拉西兰 (zerlasiran) 和穆瓦拉普林 (muvalaplin) 这样的新疗法显示出降低Lp (a) 水平的显著潜力.
- 这些疗法可以为高风险人群提供有针对性的干预措施.
- 在Lp (a) 试验标准化和异型特征化方面仍然存在挑战.
结论:
- 由于其在ASCVD中既定的作用,Lp (a) 是心血管研究和治疗的关键目标.
- 将Lp (a) 测量纳入风险评估可以改善患者分层并指导有针对性的干预措施.
- 新兴的Lp (a) 降低疗法有望减少心血管事件.
更多相关视频
08:45LDL Cholesterol Uptake Assay Using Live Cell Imaging Analysis with Cell Health Monitoring
Published on: November 17, 2018
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...